Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06042153 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

DIALYSIS-TIR Study

StatusActive, Not Recruiting
PhasePhase 4
Started2023-12-05
View on ClinicalTrials.gov ↗

Amendment history

2026-01-09
Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v4
Trial statusRecruiting→Active, Not Recruiting
Enrollment targetestimated 157→confirmed 43
Study sitesdetails revised at 5 of 5 sites
2025-02-12
Study Status, Contacts/Locations v3
Primary completion date2025-09→2027-09
Completion date2026-09→2028-09
Study sitesdetails revised at 3 of 5 sites
2024-02-11
Study Status, Contacts/Locations v2
Study sites3→5
2024-01-09
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2023-12→confirmed 2023-12-05
Study sites1→3
2023-09-11
Original filing
This study will look at control of blood sugar levels in persons with type 2 diabetes mellitus currently on chronic dialysis. Researchers will compare blood sugar levels in people taking semaglutide to people taking "dummy" medicine. The treatment participants get will be decided randomly. Participants will need to inject the study medication once a week. The study will last for 1 year and a month. Participants will be asked to wear a sensor that measures blood sugar levels for a period of 10 days at five different time points during the study.
Trial Details
NCT Number NCT06042153
Lead Sponsor University of Texas Southwestern Medical Center
Collaborators: University of North Carolina, Chapel Hill
Conditions Type 2 Diabetes, End Stage Renal Disease on Dialysis
Enrollment 43 participants
Start Date 2023-12-05
Primary Completion 2027-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-01-13